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Neuromyelitis optica spectrum disorders (NMOSD) are rare but debilitating conditions with an estimated prev-
alence of 0.52 to 4.4 per 100,000 population1. Classic NMO is characterized by optic neuritis and longitudi-
nally extensive transverse myelitis (LETM)2. NMOSD initially presents as a limited form of optic neuritis or 
LETM, whose diagnosis can be supported by a positive serological test of autoantibodies against aquaporin-4 
(AQP4)3. he term NMOSD encompasses classic NMO and cases with or without autoantibodies against AQP44. 
Approximately a quarter of AQP4 seronegative NMOSD patients have antibodies against myelin oligodendrocyte 
glycoprotein (MOG)5. NMOSD are associated with reduced quality of life and increased mortality.
Many patients with NMOSD exhibit normal brain magnetic resonance imaging (MRI) indings at diagnosis, 
despite the fact that cavitation, suggesting a necrotizing process, is frequently found histologically in lesions in 
the medulla oblongata, spinal cord, and optic nerves6,7. Whether normal-appearing white matter (NAWM) on 
imaging studies for NMOSD is indeed normal is still open to debate. he magnetization transfer ratio (MTR) 
of NAWM at 1.5 Tesla (T) did not difer between NMOSD and healthy controls8,9. he difusion tensor imaging 
(DTI) at 3T revealed abnormalities conined to the optic and corticospinal tracts10,11. In contrast, patients with 
multiple sclerosis (MS) have multiple brain white matter (WM) lesions, where demyelination and remyelina-
tion is the characteristic histological inding12. Both lesions and NAWM in MS patients have been quantiied 
using quantitative T1 mapping and MTR, with demyelination, inlammation, oedema and tissue disorganisation 
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being assessed histopathologically12–15. In addition, at 7T, both quantitative T1 mapping and the MTR can detect 
changes within NAWM in clinically isolated syndromes and relapsing-remitting MS (RRMS) relative to healthy 
controls16 via imaging with submillimetre resolution. Quantitative imaging at 7T is capable of revealing the dam-
aged substrate within WM lesions and NWAM in NMOSD.
Based on aforementioned MRI and histological indings, we hypothesized that (1) the extent of structural 
change of WM lesions in NMOSD is more severe than in MS, but that (2) the integrity of NAWM in NMOSD is 
less compromised than in MS. herefore, we prospectively enrolled patients with NMOSD, patients with MS, and 
healthy participants and acquired brain MRI images at 7T, for comparison of the measured T1 relaxation time 
and MTR maps among the groups.
Results
Ǥ We prospectively investigated 36 participants: 14 patients with NMOSD, 
12 patients with MS, and 10 healthy participants. Ten (71%) of the patients with NMOSD had classic NMO 
(Supplementary Table 1). Eight (67%) of the patients with MS had RRMS, two (17%) had secondary progressive 
MS (SPMS), and two (17%) had primary progressive MS (PPMS).
he date of the MRI scan was separated from a clinical attack by at least 30 days. One of the patients with 
NMOSD was treated with corticosteroids alone, and the others received long-term immunosuppressants: ive had 
azathioprine, ive had rituximab, and three had mycophenolate mofetil; of these patients, three combined their 
treatment with low-dose corticosteroids. Four patients with MS received long-term immunomodulatory agents: 
one used interferon beta-1a, one glatiramer acetate, one natalizumab, and one dimethyl fumarate.
Ǥ Clinical characteristics and functional assessment results are summarized in Tables 1 
and 2, respectively. here were no signiicant diferences in disease duration, Expanded Disability Status Scale 
(EDSS) score, self-administered Fatigue Severity Scale (FSS) score, quantitative functional test results of leg func-
tion/ambulation (Timed 25-Foot Walk), or arm function (9-Hole Peg Test) between the patients with MS and 
NMOSD. However, cognitive function (Paced Auditory Serial Addition Test with a 3-second interstimulus inter-
val, PASAT-3) was signiicantly lower in the patients with NMOSD than in MS patients (mean number of correct 
responses, 34.1 vs. 47.6, respectively; p = 0.006). he Multiple Sclerosis Functional Composite (MSFC) scores 
derived by summing the three aforementioned components were similar between the NMOSD and MS patients. 
he scores were signiicantly worse in NMOSD and MS patients than in controls except for cognitive function 
(PASAT-3), which was similar between the patients with MS and controls. In healthy controls, age was only neg-
atively correlated with hand function score (rho = −0.665, p = 0.036).
Ǥ Lesions. Lesion count and volume, and the quantitative T1 and MTR of the lesions were measured 
in each subject. he lesion count and volume were signiicantly higher in patients with MS than in those with 
NMOSD or healthy controls (Table 3). he lesions were mainly localized in the supratentorial regions of patients 
with MS, and in the infratentorial regions of patients with NMOSD. A few incidental, small and nonspeciic 
lesions in the supratentorial deep WM were identiied in four controls. he lesions in the patients with MS had a 
signiicantly higher measured T1 than those in patients with NMOSD or controls. Similarly, MS lesions had the 
lowest mean lesion MTR value, followed by NMOSD lesions. here was a correlation between mean T1 and mean 
MTR for the lesions in patients with NMOSD (Spearman’s rho = −0.800, p = 0.001) and for those of patients with 
MS (rho = −0.912, p < 0.001).
In the patients with NMOSD, the mean lesion T1 was negatively correlated with cognition score 
(rho = −0.592, p = 0.033). In the patients with MS, lesion volume was positively correlated with disease duration, 
and negatively correlated with hand function score.
NAWM. he T1 and MTR were calculated for the NAWM and histogram metrics were used to asses this, to 
increase power by comparing the whole region of interest (ROI). he results are shown in Table 4, and averaged 
histograms are shown in Fig. 1. he heights of the peaks of both the T1 and MTR histograms of the NAWM of the 
NMOSD
(n = 14)
MSa
(n = 12)
Controls
(n = 10) P
Median age, years (IQR) 54.0 (37.0–63.0) 55.5 (40.5–63.5) 44.5 (24–57) 0.416
Female, n (%) 10 (71) 7 (58) 7 (70) 0.769
Presence of serum Ab, n (%)
NMO-IgG/AQP4: 8 (57)
MOG: 1 (7)
n/a n/a
Median disease duration, years (IQR) 8 (3.0–11.0) 13 (7.5–20.5) n/a
Receiving immunosuppressants or 
immunomodulatory agents, n (%)
14 (100)b 5 (42)c n/a .
Table 1. Comparisons of demographic and clinical characteristics between the patients with NMOSD, patients 
with MS and healthy controls. Abbreviations: Ab, antibody; AQP4, aquaporin 4; IgG: immunoglobulin G; IQR, 
interquartile range; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; NMO, neuromyelitis 
optica; NMOSD, neuromyelitis optica spectrum disorders; n/a, not applicable or not available; SD, standard 
deviation. aEight (67%) MS patients had relapsing remitting MS, two (17%) had secondary progressive MS, and 
two (17%) had primary progressive MS.
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NMOSD patients were signiicantly lower than those in the healthy subjects, but were not diferent from those 
of the patients with MS. he peak position was not statistically diferent among the three groups; however, in the 
patients with MS, the 25th percentile MTR value was lower than that for the healthy participants. his pattern 
indicates that there are focal areas of abnormality rather than difuse abnormality within the voxels.
In the patients with MS, T1 histogram metrics were correlated with MSFC score, and MTR histogram metrics 
were correlated with leg function score using Spearman’s rank correlation coeicient (Table 5). No such correla-
tions were noted in the patients with NMOSD.
Lesion volume and NAWM. In the patients with NMOSD, both the T1 and MTR histogram metrics of the 
NAWM were correlated with lesion volume. No such correlation was found in the patients with MS.
NMOSD
(n = 14)
MS
(n = 12)
Controls
(n = 10) P
Median EDSS and FSS (IQR)
   EDSS
5.25 (4.0–6.0) 6.0 (4.0–6.5) n/a
n = 12 n = 12 n = 10
   FSS 5.6 (5.3–6.3)A 6.0 (4.9–6.4)A 2.1 (1.2–2.6)B <0.001*
Mean MSFC raw score and z-scorea (±SD)
T25-FWb n = 11 n = 12 n = 10
   Raw score, s 8.56 ± 2.46A 9.98 ± 4.14A 4.59 ± 0.30B <0.001*
   Z-score −13.40 ± 8.31A −17.69 ± 14.56A 0 ± 1B <0.001*
9HPT n = 14 n = 12 n = 10
   Raw score dominant hand, s 34.83 ± 24.79A 27.83 ± 4.80A,B 17.60 ± 1.93B 0.044*
   Raw score nondominant handc, s 86.48 ± 199.24 31.85 ± 12.10 19.95 ± 2.75 0.375
   Z-score of both hands −3.89 ± 2.00A −3.42 ± 1.20A 0 ± 1B <0.001*
PASAT-3d n = 13 n = 10 n = 10
   Raw score (correct number/60) 34.15 ± 10.58 A 47.60 ± 10.29B 52.00 ± 6.68B <0.001*
   Z-score −2.67 ± 1.58 A −0.66 ± 1.54 A 0 ± 1B <0.001*
MSFC sum score n = 10 n = 10 n = 10
   Z-scoree −6.72 ± 2.84 A −6.05 ± 4.8A 0 ± 0.57B <0.001*
Table 2. Comparisons of EDSS, FSS, and MSFC between the 14 patients with NMOSD, 12 patients with MS, 
and 10 healthy controls. Abbreviations: EDSS, Expanded Disability Status Scale; FSS, Fatigue Severity Scale; 
IQR, interquartile range; MSFC, Multiple Sclerosis Functional Composite; MS, multiple sclerosis; n/a, not 
applicable or not available; NMOSD, neuromyelitis optica spectrum disorders; PASAT-3, Paced Auditory 
Serial Addition Test with a 3-second interstimulus interval; SD, standard deviation; T25-FW, Timed 25-
Foot Walk Test; 9HPT-dominant, 9-Hole Peg Test of the dominant hand. A,B,Che same character indicates 
no diference between groups, while a diferent character indicates a diference. aA z-score is a standardized 
number, in this study representing how close a test result is to the mean of 10 healthy controls and expressed 
as a standard deviation. A negative z-score indicates that the test result was worse than the mean performance 
of the 10 healthy controls, and the value indicates the number of standard deviations. bhe T25-FW could not 
be performed in two patients with NMOSD because of limited physical ability, and was not completed in one 
patient with NMOSD because of physical fatigue. cOne subject with NMOSD was unable to perform the test on 
the non-dominant hand because of limited physical ability, so a value of 777 seconds was applied as suggested by 
the MSFC scoring manual. dOne patient with NMOSD and two with MS refused to perform the PASAT-3 test 
because they stated that they did not understand the principle of the test. ehe MSFC sum Z score was calculated 
for subjects who completed all tests by combining the three components into a single z score.
NMOSD
(n = 14)
MS
(n = 12)
Controls
(n = 10) P
Lesion count
(median, IQR)
11A
(2.0–18.0)
74B
(33.5–112.5)
0A
(0.0–3.0)#
<0.001*
Lesion volume (mm3)
(median, IQR)
242.4A
(60.7–696.0)
5217.0B
(2356.8–9488.2)
0A
(0–27.2)#
<0.001*
T1 relaxation time (ms)
Mean ± SD
1869 ± 367A 2163 ± 268B 1511 ± 117A 0.003*
MTR (%)
Mean ± SD
38.8 ± 6.5A 32.0 ± 4.6B 46.5 ± 3.8C <0.001*
Table 3. Comparison of lesion load, T1 relaxation time and MTR among the NMOSD patients, MS patients 
and healthy controls. Abbreviations: IQR, interquartile range; MS, multiple sclerosis; MTR, magnetization 
transfer ratio; NMOSD, neuromyelitis optica spectrum disorders; SD, standard deviation. #Among the 10 
healthy controls, 4 had incidental indings of at least one nonspeciic white matter lesion. A,B,Che same 
character indicates no diference between groups, while a diferent character indicates diference.
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Discussion
his study used high-resolution 7T MRI to compare the T1 and MTR of intracranial lesions and NAWM among 
NMOSD patients, MS patients, and healthy controls. Compared to MS lesions, the NMOSD lesions showed less 
obvious tissue changes. Regarding the NAWM, NMOSD patients had a lower histogram peak height for both 
T1 and MTR compared to controls. None of the histogram metrics were signiicantly diferent from those of the 
patients with MS although there was a trend towards the NMOSD measures difering less from those of the con-
trols compared to the MS patients, similar to the trends in changes observed in the lesions. he decreased peak 
height of NAWM in both the MS and NMOSD patients indicated that at least some of the NAWM in the patients 
with NMOSD was abnormal, as has been shown in patients with MS. he histogram metrics for the NAWM were 
correlated with lesion volume in the patients with NMOSD, but not in those with MS. Taken together, our study 
suggests that the NMOSD lesions had less myelin damage than the MS lesions, and that the NAWM in patients 
with NMOSD is abnormal, where the abnormal changes were correlated with lesion volume.
T1 is an intrinsic biophysical property of tissue, and is primarily determined by water binding to macromol-
ecules, including myelin. In MS, increased T1 of the WM is highly associated with reduced structural integrity, 
and black holes (the darkest area on T1 weighted images) have the highest T113. An elevated T1 correlates with 
a loss of myelin, axons14 and increased free water, which to some extent relects gliosis by virtue of the increase 
in water protons17. Magnetization transfer (MT) imaging measures proton exchange between free protons and 
macromolecular bound protons and provides a relatively accurate measurement of the myelin content12,18. Our 
MS results for the lesions were similar to those observed in previous studies, relecting decreased myelin content 
and tissue integrity, which can be due to demyelination or incomplete remyelination12,15.
Our results showed an abnormal mean MTR, but not T1, in the lesions of patients with NMOSD. However 
the deviation from normal was smaller than in the patients with MS. Our indings reject the irst hypothesis. In 
contrast to previous histopathological indings of focal necrosis in autopsied patients with fulminant NMO6,7, 
the patients with NMOSD in the current study had fewer destructive lesions in the brain overall than those with 
MS. One possible explanation for this is that our patients with NMOSD beneited from efective treatment such 
as plasma exchange, immunosuppressants or B cell depletion therapy. Another possibility is lesion heterogeneity, 
as the standard deviation of lesion T1 and MTR in NMOSD patients, was as wide as that in MS patients, and 
several types of lesions have been reported in NMOSD6,19. he histopathological hallmark of the active lesions 
of NMOSD patients with AQP4 antibodies is loss, or decreased staining, of AQP4 protein, and an absence of 
astrocytes or loss of astrocyte distal processes19, thus disrupting the cerebrospinal luid (CSF)-brain barrier and 
blood-brain barrier, and leading to necrosis6,20. Nevertheless, the early active lesions in NMOSD patients showed 
relative preservation of myelin compared to those of MS patients19. However, these changes may not contribute 
suicient water to account for the observed changes measured by T1, because other alterations, such as iniltra-
tion of eosinophils or granulocytes, have also been observed6. Furthermore, the patients with MS in this study 
had a relatively longer disease course than those with NMOSD; as such, tissue destruction of chronic lesions may 
be more obvious in MS. Overall, our results seem to be compatible with the known pathological characteristics of 
primary astrocytopathy occurring in NMOSD, and primary demyelination occurring in MS21.
In this study, histogram metrics were used to assess the NAWM to provide maximum power to detect changes. 
he histogram metrics were statistically indistinguishable between the NMOSD and MS patients, rejecting the 
second hypothesis. Regarding the T1 histogram of patients with PPMS, the peak height decreased and the peak 
position increased; therefore, the histogram metrics shited rightwards over 2 years22. If myelin was reduced in 
the NAWM, the histogram metrics would shit letwards, such that the peak height and peak position would both 
decrease. Previous studies have shown that abnormalities in MS NAWM are subtype-dependent23: SPMS shows 
NMOSD
(n = 14)
MS
(n = 12)
Controls
(n = 10) P
T1 relaxation time (mean ± SD)
Peak height (10–3 pixels) 5.9 ± 1.5A 5.6 ± 1.2A 6.8 ± 1.0B 0.067*
Peak position (ms) 1244 ± 43 1265 ± 47 1264 ± 25 0.915
25th percentile (ms) 1203 ± 40 1217 ± 31 1218 ± 27 0.990
50th percentile (ms) 1259 ± 49 1282 ± 37 1265 ± 23 0.604
75th percentile (ms) 1321 ± 64 1353 ± 55 1312 ± 22 0.204
MTR (mean ± SD)
Peak height (10-3, pixels) 7.7 ± 1.5A 6.7 ± 1.3A 8.9 ± 1.0B 0.002*
Peak position (%) 55.8 ± 3.4 54.2 ± 3.2 56.2 ± 3.8 0.401
25th percentile (%) 51.5 ± 2.9 A 49.3 ± 3.3B 52.5 ± 3.5A 0.081*
50th percentile (%) 55.4 ± 3.1 53.9 ± 2.9 55.7 ± 3.6 0.400
75th percentile (%) 59.1 ± 3.3 58.4 ± 3.0 58.9 ± 3.8 0.926
Table 4. Comparisons of the NAWM histogram metrics, as indexed by T1 relaxation time or MTR, among 
the NMOSD patients, MS patients and healthy controls. he mean values of ive parameters for each group 
(the height and position of the histogram peak and the 25th, 50th and 75th percentile values) were included in 
the analysis. Abbreviations: NMOSD, neuromyelitis optica spectrum disorders; MS, multiple sclerosis; MTR, 
magnetization transfer ratio; SD, standard deviation. A,B,Che same character indicates no diference between 
groups, while a diferent character indicates a diference.
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changes in both the peak position and height of NAWM histograms, whereas RRMS and PPMS show decreased 
height only23–25. Since our study included more patients with RRMS and PPMS, a change in NAWM peak location 
was not observed. However, our patients with MS showed a decrease in the peak height of both the T1 and MTR 
NAWM histograms, suggesting a decreased proportion of normal WM. he results also revealed a decreased 
proportion of normal WM in patients with NMOSD compared to controls.
he results of the current study are in line with previous DTI studies of changes in the microstructural difu-
sivity of WM tracts in optic tracts, medulla oblongata, and corticospinal tracts8,10,11, and provide further evidence 
of reduced myelin content in the NAWM of NMOSD patients, based on myelin content-speciic MT imaging. 
DTI, a tool for investigating the microstructural difusivity of WM tracts, revealed abnormalities in optic tracts, 
the corpus callosum, the medulla oblongata, and corticospinal tracts in NMOSD patients8,10,26–28. DTI at 3T 
showed greater difusivity changes in the NAWM of 93 patients with NMOSD compared to 43 healthy controls, 
and the extent of DTI-detectable NAWM changes was less than that in 53 patients with MS11. Measuring changes 
in the difusion of water in directional structures, such as nerve bundles, in the brain provides insights into the 
structural integrity, in terms of myelin and axonal content, of MS patients29,30. However, NAWM axons in patients 
with NMOSD seemed not to be afected, as measured by MR spectroscopy at 1.5T or 3T ield strength16,31,32. 
Using MTR quantitative imaging at 1.5T ield strength to evaluate the NAWM of NMO patients, two earlier 
Figure 1. he averaged histograms of the normal-appearing white matter (NAWM) in neuromyelitis optica 
spectrum disorder (NMOSD; blue) patients, multiple sclerosis (MS; red) patients and healthy controls (green). 
(a) T1 relaxation time (T1): the average peak height in the T1 histogram of the NAWM of NMOSD patients 
was signiicantly lower than that in healthy subjects and did not difer from that in MS patients, relected in 
the greater width of the NMOSD and MS histograms. he peak position was not statistically diferent among 
the three groups. (b) Magnetization transfer ratio (MTR): he average peak height in the MTR histogram of 
the NAWM of NMOSD patients was signiicantly lower than that in healthy subjects and did not difer from 
that in MS patients, relected in the relative widths of these frequency histograms. he peak position was not 
statistically diferent among the three groups, but in MS patients, the 25th percentile value for MTR was lower 
than in healthy participants.
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studies did not ind altered MTR parameters8,33. However, using 7T MRI, we found evidence of changes in myelin 
in the NAWM of patients with NMOSD.
he abnormal indings in the NAWM of the patients with NMOSD noted in this study appear to be robust, 
because they were shown by two different MRI techniques based on different physical principles. MTR at 
1.5T failed to distinguish the NAWM between NMOSD and controls, in terms of either mean values or peak 
heights8,33. However, using 7T MRI, we found evidence of abnormal myelin and water content in NAWM, and 
this change was correlated with lesion volume mainly localized in the infratentorium. We assume that we were 
able to detect MTR changes because of the ultra-high ield strength. It is possible that the diference in spatial 
resolution between our study and those using lower ield strengths made it easier to observe smaller changes 
in NAWM herein. his could be veriied by repeating the 7T scanning at the spatial resolution used in previous 
lower ield strength studies. Histopathological studies to clarify the current indings pertaining to the NAWM are 
also warranted. Nevertheless, the current study did not ind an association between cognition and MRI parame-
ters. his may be attributed to the small number of patients and the mixture of NMOSD subtypes.
Several limitations of the current study deserve discussion. First, the number of patients included was small. 
We intentionally included diferent MS subtypes, based on prior knowledge of the likelihood of NAWM abnor-
malities, to match for disability levels. However, the mixture of phenotypes may have introduced bias, including 
in the cognition measures. Second, lesion detection was performed using MTsat (MTR based on proton- and 
T2*-weighted imaging with presaturation to water) images, which might not be as accurate as 3T luid-attenuated 
inversion recovery (FLAIR) images. However, we previously showed that 7T-MTsat sequences detected most of 
Lesion NAWM T1 relaxation time NAWM MTR
Volume Mean T1
Mean 
MTR
Peak 
height
Peak 
position p25 p50 p75
Peak 
height
Peak 
position p25 p50 p75
NMOSD
Disease duration −0.228 −0.104 0.009 0.320 −0.300 −0.283 −0.369 −0.413 0.205 0.384 0.501 0.426 0.340
EDSS −0.206 −0.048 −0.170 −0.213 −0.327 −0.347 −0.191 −0.041 −0.183 0.052 0.141 0.177 0.219
FSS −0.392 −0.332 0.513 0.612* −0.173 −0.138 −0.330 −0.448 −0.144 0.443 0.415 0.429 0.416
MSFC-z score 0.454 0.021 0.112 0.022 0.514 0.590 0.436 0.239 0.106 −0.094 −0.175 −0.255 −0.312
T25-FW-z score 0.405 0.033 0.092 −0.019 0.479 0.524 0.390 0.220 −0.014 0.030 −0.050 −0.090 −0.113
9HPT-z score −0.299 0.415 −0.134 0.065 −0.199 −0.189 −0.168 −0.137 0.120 0.433 0.385 0.374 0.308
PASAT3-z score 0.325 −0.592* 0.332 0.093 0.048 −0.077 −0.139 −0.198 −0.003 −0.031 0.040 0.031 0.059
Lesion volume 1 −0.080 −0.173 −0.263 0.715** 0.604* 0.611* 0.516 0.147 −0.584* −0.542* −0.587* −0.553*
Lesion mean T1 −0.080 1 −0.800** 0.169 −0.006 0.057 0.017 −0.034 0.473 −0.014 0.044 −0.083 −0.216
Lesion mean 
MTR
−0.173 −0.800** 1.000 0.184 −0.254 −0.237 −0.293 −0.274 −0.404 0.307 0.216 0.312 0.391
MS
Disease duration 0.639* 0.054 −0.266 0.498 −0.029 −0.044 −0.103 −0.161 0.347 −0.597* −0.301 −0.499 −0.591*
EDSS 0.375 0.377 −0.211 −0.204 0.202 0.169 0.374 0.453 0.007 −0.195 −0.137 −0.123 −0.082
FSS 0.190 −0.126 0.188 −0.019 −0.113 0.029 0.219 0.356 −0.012 −0.034 −0.062 0.028 0.132
MSFC-z score −0.465 −0.134 −0.014 0.634* −0.886** −0.710* −0.813** −0.842** −0.193 0.512 0.446 0.482 0.505
T25-FW-z score −0.498 −0.236 0.120 0.310 −0.253 −0.329 −0.568 −0.638* 0.057 0.644* 0.588* 0.606* 0.525
9HPT-z score −0.828** −0.414 0.520 −0.088 −0.204 −0.317 −0.452 −0.468 −0.075 0.299 0.231 0.243 0.219
PASAT3-z score −0.174 0.014 −0.009 0.722* −0.406 −0.248 −0.303 −0.318 0.529 0.320 0.377 0.251 0.152
Lesion volume 1 0.217 −0.467 0.333 0.373 0.267 0.288 0.210 0.463 −0.299 −0.057 −0.229 −0.367
Lesion mean T1 0.217 1 −0.912** −0.351 0.003 0.105 0.307 0.431 −0.331 −0.071 −0.205 −0.085 0.051
Lesion mean 
MTR
−0.467 −0.912** 1.000 0.141 −0.037 −0.053 −0.204 −0.300 0.148 0.060 0.119 0.061 −0.007
Healthy controls
FSS −0.572 0.047 −0.060 0.049 0.024 0.022 −0.082 −0.046 −0.038 −0.028 −0.020
MSFC-z score 0.244 0.336 −0.106 −0.082 −0.236 −0.398 −0.054 0.010 −0.044 −0.045 −0.051
T25-FW-z score 0.441 0.444 0.035 0.158 0.016 −0.155 0.322 −0.506 −0.509 −0.527 −0.543
9HPT-z score −0.093 0.452 0.270 0.254 0.106 −0.184 0.168 0.246 0.279 0.243 0.197
PASAT3-z score 0.066 −0.324 −0.486 −0.552 −0.524 −0.338 −0.582 0.276 0.155 0.208 0.259
Lesion volume 1 0.060 −0.128 −0.202 −0.270 −0.337 0.081 −0.207 −0.285 −0.283 −0.287
Table 5. Correlation coeicients of MRI metrics of normal-appearing white matter, lesion parameters and 
clinical factors. *Correlation signiicant at the 0.05 level (2-tailed). **Correlation signiicant at the 0.01 
level (2-tailed). Abbreviations: EDSS, Expanded Disability Status Scale; FSS, Fatigue Severity Scale; MSFC, 
Multiple Sclerosis Functional Composite; MS, multiple sclerosis; MTR, magnetization transfer ratio; NMOSD, 
neuromyelitis optica spectrum disorders; PASAT-3, Paced Auditory Serial Addition Test with a 3-second 
interstimulus interval; p25, 25th percentile; p50, 50th percentile; p75, 75th percentile; T1, T1 relaxation time; 
T25-FW, Timed 25-Foot Walk Test; 9HPT, 9-Hole Peg Test.
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the WM lesions identiied by 3T-FLAIR sequences, and missed only approximately 1.5% of small lesions34; hence, 
patients do not need to undergo both 7T and 3T scans on the same day. hird, the temporal lobes were not all 
included because the signal loss caused by inhomogeneity in the applied transmit radiofrequency (RF) ield at 
high ield strength was more pronounced in these regions.
Furthermore, the NAWM map included supratentorial, basal ganglia and infratentorial regions, where pathol-
ogy of the basal ganglia and infratentorial brain might be diferent from that of supratentorial areas; further stud-
ies are needed to clarify this. Nevertheless, the current study was strengthened by the piloting of two quantitative 
methods based on 7T MRI, used to compare two groups of patients matched for demographic characteristics and 
level of disability.
Conclusions
Our analysis of T1 and MTR values suggested that the lesions in the NMOSD patients had decreased myelin sig-
nal, but the changes therein were less pronounced compared to those in the patients with MS, in turn suggesting 
that they were less myelin-destructive. 7T MRI demonstrated a decreased peak height of NAWM histograms in 
NMOSD patients compared to controls. However, the histogram metrics were statistically indistinguishable from 
those in the patients with MS, suggesting that at least part of the NAWM in the patients with NMOSD was indeed 
abnormal, with reduced myelin, which had not been previously observed using MRI at a lower ield strength.
Methods
his study was approved by our local Research Ethics Committee (REC), and by the relevant National Health 
Service (NHS) Research & Development (R&D) department (REC reference: 13/EM/0080). he research was 
performed in accordance with relevant guidelines and regulations. Informed consent was obtained from all 
participants.
Ǥ Consecutive patients with NMOSD referred to the Neuroimmunology Clinic of University Hospital 
Nottingham, between July 2013 and November 2014, were enrolled at the Sir Peter Mansield Imaging Centre 
(SPMIC) at the University of Nottingham. Patients were eligible if (1) they had a diagnosis of NMOSD4 or MS35 as 
assessed by specialists, and (2) they were clinically stable, fully conscious and orientated. Age- and sex-matched 
patients with MS were recruited simultaneously. We used posters to recruit healthy volunteers, who were inter-
viewed by a neurologist. he exclusion criteria included claustrophobia, metal objects or devices implanted in the 
body, and pregnancy. he patients were assessed using the EDSS, MSFC, and FSS. Healthy volunteers were only 
assessed with the MSFC and FSS.
Ǥ All participants underwent MRI scanning using a 7T Philips Achieva (Philips 
Medical Systems, Best, he Netherlands) with whole-body gradients. he scanner was equipped with a 32-channel 
head-only parallel imaging sensitivity encoding (SENSE) receiver coil and a head-only volume quadrature RF coil 
(Nova Medical, Inc., Wilmington, MA, USA). he parameters of the MRI sequences are detailed in Supplementary 
Table 2, and the techniques used have been detailed previously36–39. Briely, whole brain three-dimensional (3D) 
phase-sensitive inversion recovery (PSIR) images (spatial resolution = 0.6 × 0.6 × 0.6 mm3) were acquired and 
segmented to obtain a WM mask39. hen, 3D magnetization-prepared rapid gradient echo (MPRAGE) sequences 
with seven inversion times were acquired (spatial resolution = 1.25 × 1.25 × 1.25 mm3) and processed to produce 
quantitative measurements of T138. In addition, MT images were acquired for quantitative measurement of MTRs 
derived from two raw images: MTnosat (proton- and T2*-weighted imaging with no presaturation), and MTsat 
(presaturation to water) (spatial resolution = 0.6 × 0.6 × 0.6 mm3)36,37. MTsat imaging was also used to identify 
lesions. he scanning protocol included a B1 map to correct the MT images for the efects of B1 inhomogeneity.
ǦǤ Firstly, we obtained a lesion mask for each subject. Lesions were visually identiied and 
outlined on MTsat using a semi-automated seed-growing technique, implemented in the in-house NeuRoi sot-
ware (http://www.nottingham.ac.uk/scs/divisions/clinicalneurology/sotware/neuroi.aspx). he lesions were 
identiied in all image slices, which covered the supratentorium, midbrain, rostral pons, and part of the cerebel-
lum. he total volume of these lesions was then calculated, and a binary lesion mask was generated using NeuRoi.
Secondly, we obtained the NAWM mask. Initially, a WM probability map was segmented from PSIR images 
using an automatic segmentation process, implemented in Statistical Parametric Mapping sotware (SPM8; http://
www.il.ion.ucl.ac.uk/spm/), with a threshold value of 0.95 to generate a binary WM mask. Next, a lesion-free 
WM mask was generated by applying the lesion masks. Subsequently, the lesion-free WM mask was eroded by 
three voxels to exclude any partial volume efects at the grey matter-WM junctions, lesion-WM or CSF-WM 
borders to generate the NAWM mask38.
hirdly, T1 and B1-corrected MTR maps were generated based on the raw images for each subject on a 
pixel-by-pixel basis. he T1 map was generated using formula (1)40,41:
α=



−



− 





M M exp
T
T
1
1
1 (1)
0
he MTR map was generated using formula (2):
=
−MT MT
MT
MTR
( )
(2)
nosat sat
nosat
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Finally, the T1 and B1-corrected MTR maps were combined with the lesion and NAWM masks, to yield lesion 
and NAWM maps for each subject (Fig. 2). All voxels of NAWM with an MTR of less than 10% were excluded 
from the analysis to efects of image noise and CSF signals42. All of the acquired images for a given subject were 
registered to the same space using FLIRT in FSL (available at www.fmrib.ox.ac.uk/fsl).
We compared lesion properties based on the mean values of the lesion maps. To detect subtle changes in 
NAWM, histogram metrics of the NAWM maps derived from each subject were normalized to the total voxel 
count to eliminate any efect of diferences in NAWM volume among subjects. he bin size for NAWM is 1 ms for 
T1 and 0.1% for MTR. Five histogram parameters were extracted: the height and position of the histogram peak 
and the 25th, 50th and 75th percentile values.
Ǥ We assumed that the peak height and position of the NAWM histogram of NMOSD 
patients were signiicantly diferent from those of healthy controls, because DTI imaging at 3T revealed difusiv-
ity changes along optic and cortico-spinal tracts10,11. Because no quantitative T1 or MTR data of NAWM at 7T 
in NMOSD patients are available, we performed a pre-protocol power calculation based on data derived from 
a previous MS study38. We calculated the T1 of WM and peak heights for 9 patients with RRMS and 11 healthy 
controls. We predicted that the diference in NAWM histograms between patients with NMOSD and controls 
would be 40% of that between MS patients and controls. To determine the actual diference using a 2-tailed t-test, 
10 subjects per group were required for 85% power at a signiicance level of 0.05, with a medium efect size.
An anticipated difficulty for 7T MRI studies of NMOSD patients is recruitment of a sufficient num-
ber of patients to obtain acceptable quality images for analysis. Some patients were too severely disabled (e.g. 
bed-ridden, limb spasticity) or lived a long distance from the 7T suite at the University of Nottingham. We 
estimated the number of MS and NMOSD patients in England using the Clinical Practice Research Datalink 
(CPRD), which is a database focused on primary care in the UK, and linked to secondary care in England. he 
estimates showed that NMOSD is very rare in England, with a prevalence rate in 2012 of 3.7 per 100,000 people 
(Chou et al., unpublished). he prevalence of MS is 70 times higher than that of NMOSD. Hence, the recruitment 
target for each group was 10 subjects.
Ǥ Comparisons of subgroups were performed using Fisher’s exact test for categorical data, 
the Mann-Whitney U test for ordinal (clinical rating scale) data, and ANOVA for continuous data. Multiple com-
parisons were conducted using the least signiicant diference (LSD) test, to identify which groups were diferent 
when ANOVA showed statistical diferences among groups. Statistical signiicance was established with a cut-of 
level of 0.1. To assess correlations between clinical parameters and MRI-derived parameters (Table 5), Spearman’s 
rank correlation coeicient (rho) was used. All statistical tests were two-tailed, and all calculations were per-
formed using SAS sotware (version 9.4; SAS Institute, Cary, NC, USA); correlation coeicients were calculated 
using the SPSS sotware package (version 22; IBM Corp, Armonk, NY, USA).

All data generated or analysed during this study are included in this article or the Supplementary Information 
Files.
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